BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11042414)

  • 1. Development of a fetal challenge method for the evaluation of bovine viral diarrhea virus vaccines.
    Brock KV; Chase CC
    Vet Microbiol; 2000 Nov; 77(1-2):209-14. PubMed ID: 11042414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection.
    Kovács F; Magyar T; Rinehart C; Elbers K; Schlesinger K; Ohnesorge WC
    Vet Microbiol; 2003 Oct; 96(2):117-31. PubMed ID: 14519330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle.
    Grooms DL; Bolin SR; Coe PH; Borges RJ; Coutu CE
    Am J Vet Res; 2007 Dec; 68(12):1417-22. PubMed ID: 18052749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation.
    Ficken MD; Ellsworth MA; Tucker CM; Cortese VS
    J Am Vet Med Assoc; 2006 May; 228(10):1559-64. PubMed ID: 16677126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine.
    Cortese VS; Grooms DL; Ellis J; Bolin SR; Ridpath JF; Brock KV
    Am J Vet Res; 1998 Nov; 59(11):1409-13. PubMed ID: 9829398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of fetal protection against experimental infection with type 1 and type 2 bovine viral diarrhea virus after vaccination of the dam with a bivalent modified-live virus vaccine.
    Fairbanks KK; Rinehart CL; Ohnesorge WC; Loughin MM; Chase CC
    J Am Vet Med Assoc; 2004 Dec; 225(12):1898-904. PubMed ID: 15643841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine viral diarrhea virus fetal persistent infection after immunization with a contaminated modified-live virus vaccine.
    Palomares RA; Marley SM; Givens MD; Gallardo RA; Brock KV
    Theriogenology; 2013 May; 79(8):1184-95. PubMed ID: 23561853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus.
    Rodning SP; Marley MS; Zhang Y; Eason AB; Nunley CL; Walz PH; Riddell KP; Galik PK; Brodersen BW; Givens MD
    Theriogenology; 2010 May; 73(8):1154-63. PubMed ID: 20181385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal protection against bovine viral diarrhoea type 1 virus infection after one administration of a live-attenuated vaccine.
    Meyer G; Deplanche M; Roux D; Moulignie M; Picard-Hagen N; Lyazrhi F; Raboisson D; Mathevet P; Schelcher F
    Vet J; 2012 May; 192(2):242-5. PubMed ID: 21689959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenically different pestivirus strains induce congenital infection in sheep: a model for bovine virus diarrhea virus vaccine efficacy studies.
    Bruschke CJ; van Rijn PA; Moormann RJ; van Oirschot JT
    Vet Microbiol; 1996 May; 50(1-2):33-43. PubMed ID: 8810006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An experimental multivalent bovine virus diarrhea virus E2 subunit vaccine and two experimental conventionally inactivated vaccines induce partial fetal protection in sheep.
    Bruschke CJ; van Oirschot JT; van Rijn PA
    Vaccine; 1999 Apr; 17(15-16):1983-91. PubMed ID: 10217598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of fetal infection in heifers challenged with bovine viral diarrhoea virus type 1a by vaccination with a type 1c or type 1a vaccine.
    Packianathan R; Clough WJ; Hodge A; Holz DK; Huang J; Bryant GL; Colantoni C
    N Z Vet J; 2017 May; 65(3):134-139. PubMed ID: 28359226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental fetal challenge using type II bovine viral diarrhea virus in cattle vaccinated with modified-live virus vaccine.
    Brock KV; Cortese VS
    Vet Ther; 2001; 2(4):354-60. PubMed ID: 19746658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic characterization of bovine viral diarrhea viruses isolated from persistently infected calves born to dams vaccinated against bovine viral diarrhea virus before breeding.
    Bolin SR; Lim A; Grotelueschen DM; McBeth WW; Cortese VS
    Am J Vet Res; 2009 Jan; 70(1):86-91. PubMed ID: 19119952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects against abortion and fetal infection following exposure to bovine viral diarrhea virus and bovine herpesvirus 1 during pregnancy in beef heifers that received two doses of a multivalent modified-live virus vaccine prior to breeding.
    Givens MD; Marley MS; Jones CA; Ensley DT; Galik PK; Zhang Y; Riddell KP; Joiner KS; Brodersen BW; Rodning SP
    J Am Vet Med Assoc; 2012 Aug; 241(4):484-95. PubMed ID: 22852575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of four commercially available multivalent modified-live virus vaccines against clinical disease, viremia, and viral shedding in early-weaned beef calves exposed simultaneously to cattle persistently infected with bovine viral diarrhea virus and cattle acutely infected with bovine herpesvirus 1.
    Chamorro MF; Walz PH; Passler T; Palomares R; Newcomer BW; Riddell KP; Gard J; Zhang Y; Galik P
    Am J Vet Res; 2016 Jan; 77(1):88-97. PubMed ID: 26709942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of the bovine fetus from bovine viral diarrhoea virus by means of a new inactivated vaccine.
    Brownlie J; Clarke MC; Hooper LB; Bell GD
    Vet Rec; 1995 Jul; 137(3):58-62. PubMed ID: 8533232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of skin samples for bovine viral diarrhea virus by use of reverse transcriptase polymerase chain reaction assay after vaccination of cattle with a modified-live bovine viral diarrhea virus vaccine.
    Corbett EM; Grooms DL; Bolin SR
    Am J Vet Res; 2012 Feb; 73(2):319-24. PubMed ID: 22280397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of foetal protection after vaccination against an experimental infection with bovine virus diarrhea virus.
    Zimmer GM; Wentink GH; Bruschke C; Westenbrink FJ; Brinkhof J; de Goey I
    Vet Microbiol; 2002 Nov; 89(4):255-65. PubMed ID: 12383635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal protection following exposure to calves persistently infected with bovine viral diarrhea virus type 2 sixteen months after primary vaccination of the dams.
    Ellsworth MA; Fairbanks KK; Behan S; Jackson JA; Goodyear M; Oien NL; Meinert TR; Leyh RD
    Vet Ther; 2006; 7(3):295-304. PubMed ID: 17039452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.